MedTrace Logo

Comparative Clinical and Radiographic Evaluation of Different Pulpotomy Materials in Primary Molars

NCT07769697 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2026-08-18

No results posted yet for this study

Summary

This randomized clinical trial compared the clinical and radiographic outcomes of ferric sulfate (FS), mineral trioxide aggregate (MTA), calcium-enriched mixture (CEM), and TheraCal PT used for pulpotomy in primary molars. A total of 140 restorable primary molars from children aged 4 to 9 years were randomly allocated to four treatment groups. Clinical and radiographic evaluations were performed at 3, 6, 9, and 12 months to compare treatment success and failure among the four pulpotomy materials.

Conditions

  • Dental Caries
  • Pulp Exposure, Dental
  • Primary Teeth
  • Primary Molar Pulpotomy

Interventions

PROCEDURE

Pulpotomy

Pulpotomy is a vital pulp therapy procedure in which the coronal pulp tissue is removed while preserving the vitality of the radicular pulp. Following hemostasis, the assigned pulpotomy material was applied according to the study protocol before definitive restoration of the tooth.

OTHER

Mineral Trioxide Aggregate (MTA)

Mineral trioxide aggregate (MTA) was used as the pulpotomy material following coronal pulp removal and hemostasis, according to the study protocol.

OTHER

Calcium-Enriched Mixture (CEM)

Calcium-enriched mixture (CEM) was used as the pulpotomy material following coronal pulp removal and hemostasis, according to the study protocol.

OTHER

Ferric Sulfate

Ferric sulfate was used as the pulpotomy material following coronal pulp removal and hemostasis, according to the study protocol.

OTHER

TheraCal PT

TheraCal PT was used as the pulpotomy material following coronal pulp removal and hemostasis, according to the study protocol.

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-21
Primary Completion
2022-10-21
Completion
2022-10-21

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07769697 on ClinicalTrials.gov